Cadre PE ratio CDRE

Share price divided by earnings per share over the last twelve months, since 2022.

Today, Oct 23, 2026: 37.0×
4-year median: 35.8×
Against its 4-year history: 60th; percentile: 0 is its lowest day, 100 its highest
4-year range: 28.6× to 372×
Peer median: 31.2×

Cadre's PE ratio is 37.0× as of Oct 23, 2026: a share price of $29.99 against $0.81 of earnings per share over the last twelve months.

That is above its 4-year median of 35.8×, close to the middle of its last 4 years.

Over that time it ranged from 28.6× in Apr 2026 to 372× in Nov 2022.

The median for 10 medical instruments and supplies stocks of a similar size is 31.2×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	37.0×	28.6×	42.1×
2025	37.4×	31.1×	47.6×
2024	38.6×	30.1×	42.8×
2023	34.6×	30.9×	297×
2022	252×	251×	372×

Against its peers

Companies in Medical - Instruments & Supplies nearest Cadre's size, closest first, today.

Company	PE ratio
CDRECadre	37.0×
BVSBioventus	19.4×
STAAStaar Surgical	323×
EYENational Vision	30.6×
IRMDIradimed	47.9×
LMATLemaitre Vascular	29.6×
INSPInspire Medical Systems	15.4×
UFPTUFP Technologies	31.9×
MOVMovado	17.5×
MDXGMimedx	97.8×
ATRCAtriCure	281×
Peer median	31.2×

Where Cadre ranks

#24of 35Medical instruments and supplies stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Cadre

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.